ESR1 and breast carcinoma: Estrogen receptor alpha (ERα), expressed in approximately 70% of invasive breast cancer cases, functions as a steroid hormone nuclear receptor and a transcription factor that, when activated by estrogen, initiates oncogenic pathways in breast cancer cells.